We are live on ! Find out more
ZIVO

Zivo Bioscience, Inc. Common Stock
ZIVO

Delisted

ZIVO was delisted on the 24th of November, 2023.

Back to rankings

2 hedge funds and large institutions have $58.3K invested in Zivo Bioscience, Inc. Common Stock in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

3% less capital invested

Capital invested by funds: $60.4K → $58.3K (-$2.07K)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CA
1
CoreCap Advisors
Michigan
$56.7K – – –
HNB
2
Huntington National Bank
Ohio
$1.66K – – –

ZIVO Hedge Fund Activity: Q3 2025 in Review

2 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Zivo Bioscience, Inc. Common Stock (ZIVO) for Q3 2025, worth a combined $58.3K — down 3.4% from $60.4K a quarter earlier.

Fund positioning in ZIVO was balanced in Q3 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held Zivo Bioscience, Inc. Common Stock (ZIVO) as of Q3 2025, unchanged from Q2 2025.
  • Funds reported $58.3K of Zivo Bioscience, Inc. Common Stock stock for Q3 2025, down 3.4% quarter-over-quarter.
  • 0 funds opened new Zivo Bioscience, Inc. Common Stock positions in Q3 2025 and 0 closed out.

Based on aggregated 13F filings for Q3 2025.